Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study

COVID Clinical Trial

Official title:

Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04368871
• Other study ID #: Covid-19/RFTC/MHC/2020
• Status: Recruiting
• Start date: April 28, 2020
• Est. completion date: May 30, 2021

Study information

• Verified date: April 2020
• Source: Max Healthcare Insititute Limited
• Contact: Bharat Aggarwal
• Phone: 9810077484
• Email: Bharat.Aggarwal[@]maxhealthcare.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

All Patient irrespective of age with confirmed COVID-19 admitted to hospital and who underwent chest radiograph will be enrolled in the study to find raduigraphic findings and their temporal changes in COVID-19.

Description:

In this prospective trial the investigator will work on radiology findings and their temporal changes in COVID-19 positive patients and who underwent chest radiograph will be enrolled in our study.

Patient selection will be consecutive in addition of age , gender and comorbid conditions clinical information will included travel,expose and contact history. All patients should be positive for COVID-19 via laboratory testing with real time reverse transcriptase polymerase chain reaction(rRT-PCR) In addition, the number of rRT-PCR tests performed on each patient, on which test a positive result was found,and the number of days between symptomology onset and date of first positive test will be recorded.

In view of the current dynamics, any other reliable diagnostic test(s) if added to the clinical protocol will also be considered for inclusion in this study.

Tabulation of radiographic findings for all consecutive X-rays will be done along with the temporal changes of these findings. further, the clinical findings with the outcomes(duration of hospital findings, ventilatory support and discharge/death).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: May 30, 2021
• Est. primary completion date: June 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

1.Patients confirmed positive for COVID-19 by rRT-PCR irrespective of age.

Exclusion Criteria:

1.Patients with flu like symptoms but negative for COVID-19 by rRT-PCR.

Related Conditions & MeSH terms

• COVID

Locations

Country	Name	City	State
India	Max Super Speciality Hospital, A Unit of Devki Devi Foundation	New Delhi

Sponsors (1)

Lead Sponsor	Collaborator
Max Healthcare Insititute Limited

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study	Determine the radiographic findings in chest X-ray of COVID-19 positive patients.	1-2 weeks
Secondary	Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study	Correlation of clinical findings with the outcomes (duration of hospital stay, ventilatory support, and discharge/death)	4-8 weeks